Malin Corporation plc (ISE:MLC)

Market Cap	30.35M -14.5%
Revenue (ttm)	n/a
Net Income	-6.90M
EPS	-0.92
Shares Out	4.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	117
Open	7.10
Previous Close	7.00
Day's Range	6.95 - 7.10
52-Week Range	6.95 - 9.30
Beta	0.43
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Malin Corporation

Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Employees: 2
• Stock Exchange: Euronext Dublin
• Ticker Symbol: MLC

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 12, 2026

Data Sources Report a data error